TPI Appoints CSO
This article was originally published in Scrip
Biosimilar company Therapeutic Proteins International (TPI) has appointed Michael W. Washabaugh chief scientific officer (CSO). Prior to this position, he held a senior leadership R&D position at MedImmune and before this he was head of vaccine and biologics analytical sciences at Merck & Co.
Register for our free email digests: